Matches in Nanopublications for { ?s ?p "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP220398.RAMTduvu1fBTsoZPxJcEQoqmCS6GzDH8ZmRZpXlsQXKeI130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220398.RAMTduvu1fBTsoZPxJcEQoqmCS6GzDH8ZmRZpXlsQXKeI130_provenance.
- NP306589.RAnCK2oBoPR4F3EMi0MaAwza-eXv_sTMOH7UvDyh8HrIo130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306589.RAnCK2oBoPR4F3EMi0MaAwza-eXv_sTMOH7UvDyh8HrIo130_provenance.
- NP491385.RATczRUySL-0SD5P1cRwDb9DQfjRD85CnqfOrDx5HvC7Y130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491385.RATczRUySL-0SD5P1cRwDb9DQfjRD85CnqfOrDx5HvC7Y130_provenance.
- assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP457825.RAc1RY_pv0GRJZwHiumYOaPOUQolqL0PrzUVh8yjkM0ys130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP457825.RAc1RY_pv0GRJZwHiumYOaPOUQolqL0PrzUVh8yjkM0ys130_provenance.
- NP727900.RAz5FBYHIeVw59qwz9HjmzbaXEWrfQsptfCW7fHVLHEy4130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP727900.RAz5FBYHIeVw59qwz9HjmzbaXEWrfQsptfCW7fHVLHEy4130_provenance.
- NP578422.RAZwzAfaA3qRTjuNbojUAbNnPEgtEINjsPxN0_8QYAC30130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578422.RAZwzAfaA3qRTjuNbojUAbNnPEgtEINjsPxN0_8QYAC30130_provenance.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.
- NP578426.RAS6NjC3JsECeIK204lc5kky5SeNLMHiITF_6-wis7VrU130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578426.RAS6NjC3JsECeIK204lc5kky5SeNLMHiITF_6-wis7VrU130_provenance.
- NP451748.RAspwg3aYlpk27LkrRgZwpdnTTiOFPpCUMompVUjR7kvo130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP451748.RAspwg3aYlpk27LkrRgZwpdnTTiOFPpCUMompVUjR7kvo130_provenance.
- NP452567.RA8f36kq8HL93h1jmRlj31htReHifGM4T4q7GdXqvonmU130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452567.RA8f36kq8HL93h1jmRlj31htReHifGM4T4q7GdXqvonmU130_provenance.
- NP453652.RAwGbBZpFR1H3JT-pXhg9Vzlx-2KasJ35VFgE-XnI4jR8130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453652.RAwGbBZpFR1H3JT-pXhg9Vzlx-2KasJ35VFgE-XnI4jR8130_provenance.
- NP578424.RAHI8yyyrT-KJD2mox0BdN2yoJOBfZJxIFTcL3Zs5OPYk130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578424.RAHI8yyyrT-KJD2mox0BdN2yoJOBfZJxIFTcL3Zs5OPYk130_provenance.